(Q28199560)

acute myocardial infarction

inferred from title

1 reference

Bruno Scheller

1

0 references

Benno Hennen

2

0 references

Bernd Hammer

3

0 references

Jürgen Walle

4

0 references

Christian Hofer

5

0 references

Volker Hilpert

6

0 references

Horst Winter

7

0 references

Georg Nickenig

8

0 references

Michael Böhm

Journal of the American College of Cardiology

9

0 references

language of work or name

English

0 references

publication date

20 August 2003

0 references

published in

0 references

volume

42

0 references

page(s)

634-41

0 references

issue

4

0 references

cites work

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Recurrent ischemia after thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUS

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 t

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infa

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900763-0

7 January 2021

10.1016/S0735-1097(03)00763-0

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_ulw2iqm4lfaldfjncryuk4gy44

2646365

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ulw2iqm4lfaldfjncryuk4gy44

24 November 2022

mapped directly with Wikidata item

2646365

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference